SAMSUNG PHARM. Co., LTD. (KRX:001360)
South Korea
· Delayed Price · Currency is KRW
1,808.00
+48.00 (2.73%)
At close: Mar 10, 2026
SAMSUNG PHARM. Co., LTD. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2018 | FY 2017 | FY 2016 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
| Market Capitalization | 165,652 | 144,757 | 145,987 | 147,229 | 166,368 | 166,026 | |
| Market Cap Growth | 19.00% | -0.84% | -0.84% | -11.50% | 0.21% | -34.48% | |
| Enterprise Value | - | - | - | 124,596 | 212,663 | 177,122 | |
| Last Close Price | 1760.00 | 1538.00 | 1962.35 | 2282.64 | 3317.58 | 3453.75 | |
| PE Ratio | 13.03 | 11.39 | 5.88 | - | - | - | |
| PS Ratio | 3.74 | 3.27 | 2.81 | 3.17 | 3.97 | 3.52 | |
| PB Ratio | - | - | - | 1.12 | 1.77 | 2.02 | |
| P/TBV Ratio | - | - | - | 1.12 | 1.78 | 2.08 | |
| P/OCF Ratio | - | - | - | - | 32.29 | - | |
| EV/Sales Ratio | - | - | - | 2.68 | 5.07 | 3.75 | |
| Debt / Equity Ratio | - | - | - | 0.14 | 0.48 | 0.54 | |
| Net Debt / Equity Ratio | - | - | - | -0.11 | 0.20 | 0.39 | |
| Net Debt / EBITDA Ratio | - | - | - | 9.15 | -4.85 | -15.42 | |
| Net Debt / FCF Ratio | - | - | - | 1.64 | -19.57 | -0.74 | |
| Asset Turnover | - | - | - | 0.30 | 0.29 | 0.35 | |
| Inventory Turnover | - | - | - | 3.81 | 3.10 | 3.37 | |
| Quick Ratio | - | - | - | 2.18 | 0.87 | 0.78 | |
| Current Ratio | - | - | - | 3.10 | 1.17 | 1.31 | |
| Return on Equity (ROE) | - | - | - | -1.84% | -8.25% | -26.77% | |
| Return on Assets (ROA) | - | - | - | -2.14% | -3.32% | -2.94% | |
| Return on Capital Employed (ROCE) | - | - | - | -4.00% | -7.60% | -6.20% | |
| Earnings Yield | 7.67% | 8.78% | 17.00% | -1.41% | -4.53% | -13.02% | |
| FCF Yield | - | - | - | -6.20% | -0.57% | -26.01% | |
| Buyback Yield / Dilution | - | - | - | -28.44% | -21.80% | -28.46% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.